This protocol applies to patients presenting with early age-related macular degeneration (AMD) — characterised by the presence of drusen and/or pigmentary abnormalities in the absence of late AMD features.
Diagnosis of early AMD is confirmed through slit-lamp biomicroscopic fundus examination, which identifies the characteristic drusen deposits and/or pigmentary changes that define this stage.
Confirm a diagnosis of early AMD using slit-lamp biomicroscopic fundus examination alone.
View source ↗